These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of erdosteine on sputum biochemical and rheologic properties: pharmacokinetics in chronic obstructive lung disease. Marchioni CF; Moretti M; Muratori M; Casadei MC; Guerzoni P; Scuri R; Fregnan GB Lung; 1990; 168(5):285-93. PubMed ID: 2126836 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study). Marchioni CF; Polu JM; Taytard A; Hanard T; Noseda G; Mancini C Int J Clin Pharmacol Ther; 1995 Nov; 33(11):612-8. PubMed ID: 8688986 [TBL] [Abstract][Full Text] [Related]
4. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis. Ricevuti G; Mazzone A; Uccelli E; Gazzani G; Fregnan GB Thorax; 1988 Aug; 43(8):585-90. PubMed ID: 3051508 [TBL] [Abstract][Full Text] [Related]
5. The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data. Cazzola M; Floriani I; Page CP Pulm Pharmacol Ther; 2010 Apr; 23(2):135-44. PubMed ID: 19854285 [TBL] [Abstract][Full Text] [Related]
6. Activity of erdosteine on mucociliary transport in patients affected by chronic bronchitis. Olivieri D; Del Donno M; Casalini A; D'Ippolito R; Fregnan GB Respiration; 1991; 58(2):91-4. PubMed ID: 1862257 [TBL] [Abstract][Full Text] [Related]
7. Erdosteine: its relevance in COPD treatment. Moretti M Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):333-43. PubMed ID: 19331595 [TBL] [Abstract][Full Text] [Related]
8. Clinical effects of erdosteine in the treatment of acute respiratory tract diseases in children. Balli F; Bergamini B; Calistru P; Ciofu EP; Domenici R; Doros G; Dragomir D; Gherghina I; Iordachescu F; Murgoci G; Orasanu D; Plesca D; Vaccaro A; Assereto R Int J Clin Pharmacol Ther; 2007 Jan; 45(1):16-22. PubMed ID: 17256446 [TBL] [Abstract][Full Text] [Related]
9. Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis. Cazzola M; Calzetta L; Page C; Rogliani P; Matera MG Pulm Pharmacol Ther; 2018 Feb; 48():185-194. PubMed ID: 29233650 [TBL] [Abstract][Full Text] [Related]
10. Erdosteine for COPD exacerbations. Drug Ther Bull; 2008 Oct; 46(10):79-80. PubMed ID: 18832259 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine. Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026 [TBL] [Abstract][Full Text] [Related]
13. Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation. Calverley PM; Page C; Dal Negro RW; Fontana G; Cazzola M; Cicero AF; Pozzi E; Wedzicha JA Int J Chron Obstruct Pulmon Dis; 2019; 14():2733-2744. PubMed ID: 31819405 [TBL] [Abstract][Full Text] [Related]
14. A controlled multicenter pediatric study in the treatment of acute respiratory tract diseases with the aid of a new specific compound, erdosteine (IPSE, Italian Pediatric Study Erdosteine). Titti G; Lizzio A; Termini C; Negri P; Fazzio S; Mancini C Int J Clin Pharmacol Ther; 2000 Aug; 38(8):402-7. PubMed ID: 10984014 [TBL] [Abstract][Full Text] [Related]
15. [Multicenter, controlled, double-blind study of the efficacy and tolerance of Vectrine (erdostein) versus placebo in the treatment of stabilized chronic bronchitis with hypersecretion]. Aubier M; Berdah L Rev Mal Respir; 1999 Sep; 16(4):521-8. PubMed ID: 10549062 [TBL] [Abstract][Full Text] [Related]
16. Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study. Abut E; Yaşar B; Güveli H; Bölükbaş C; Bölükbaş FF; Dalay AR; Kurdaş OO Scand J Gastroenterol; 2010 Jun; 45(6):677-83. PubMed ID: 20334478 [TBL] [Abstract][Full Text] [Related]
17. Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent. Cazzola M; Page C; Rogliani P; Calzetta L; Matera MG Drugs; 2020 Nov; 80(17):1799-1809. PubMed ID: 33025535 [TBL] [Abstract][Full Text] [Related]
18. Acute and Chronic Effects of Oral Erdosteine on Ciliary Beat Frequency, Cough Sensitivity and Airway Reactivity. Pappová L; Kazimierová I; Jošková M; Šutovská M; Fraňová S Adv Exp Med Biol; 2018; 1023():1-10. PubMed ID: 28730380 [TBL] [Abstract][Full Text] [Related]
19. Erdosteine enhances mucociliary clearance in rats with and without airway inflammation. Hosoe H; Kaise T; Ohmori K J Pharmacol Toxicol Methods; 1998 Oct; 40(3):165-71. PubMed ID: 10334633 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial. Dal Negro RW; Visconti M; Turco P Pulm Pharmacol Ther; 2015 Aug; 33():47-51. PubMed ID: 26116425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]